Literature DB >> 15865110

Preoperative assessment of small tumours in women with breast cancer.

B A Kald1, P Boiesen, K Ronnow, P E Jonsson, T Bisgaard.   

Abstract

BACKGROUND AND OBJECTIVES: In patients with breast cancer, planning of the surgical strategy may rely on preoperative tumour size. The optimal method for assessment of small tumours has not been established. We compared findings from preoperative mammography and ultrasonography with histopathological tumour size in patients treated with breast-conserving surgery.
MATERIAL AND METHODS: The study was retrospective and the setting a single institution clinic with free referral of patients. The patients were examined before the operation with mammography, ultrasonography, and findings were compared with postoperative histopathological tumour size.
RESULTS: The study included 131 patients (median age was 59) years with grade I, II, and III cancers in 47, 71 and in 13 patients, respectively. The medium histological tumour size was 14 mm, range 4-45 mm. A wide 95% confidence interval between histopathological tumour size and preoperative mammography (standard deviation 4.8 mm) and ultrasonography (standard deviation 4.8 mm) was found. The combination of mammography and ultrasonography did not improve the results (standard deviation 4.3 mm). Preoperative mammography tended to over estimate the tumour size compared with histological tumour size whereas preoperative ultrasonography tended to underestimate the tumour size.
CONCLUSION: In this retrospective study with preoperative evaluation of small breast cancers by mammography and ultrasonography, wide 95% confidence intervals for the methods were found and they should therefore be used with caution in the planning of the surgical strategy.

Entities:  

Mesh:

Year:  2005        PMID: 15865110     DOI: 10.1177/145749690509400105

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  6 in total

1.  Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer.

Authors:  Jason D Keune; Donna B Jeffe; Mario Schootman; Abigail Hoffman; William E Gillanders; Rebecca L Aft
Journal:  Am J Surg       Date:  2010-04       Impact factor: 2.565

2.  Tumor size of breast invasive ductal cancer measured with contrast-enhanced ultrasound predicts regional lymph node metastasis and N stage.

Authors:  Zhiyuan Wang; Qichang Zhou; Jun Liu; Shichu Tang; Xia Liang; Zhengyu Zhou; Ying He; Hui Peng; Yuanming Xiao
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

3.  Clinical assessment of axillary lymph nodes and tumor size in breast cancer compared with histopathological examination: a population-based analysis of 2,537 women.

Authors:  Shabaz Majid; Ingrid Tengrup; Jonas Manjer
Journal:  World J Surg       Date:  2013-01       Impact factor: 3.352

4.  Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer.

Authors:  Peixian Chen; Chuan Wang; Ruiliang Lu; Ruilin Pan; Lewei Zhu; Dan Zhou; Guolin Ye
Journal:  Breast Care (Basel)       Date:  2021-12-23       Impact factor: 2.268

5.  Comparison of mammography and ultrasound in detecting residual disease following bioptic lumpectomy in breast cancer patients.

Authors:  Xiufeng Wu; Qingzhong Lin; Jianping Lu; Gang Chen; Y I Zeng; Yinglan Lin; Ying Chen; Yaoqin Wang; Jun Yan
Journal:  Mol Clin Oncol       Date:  2016-01-14

6.  Neo-adjuvant capecitabine chemotherapy in women with newly diagnosed locally advanced breast cancer in a resource-poor setting (Nigeria): efficacy and safety in a phase II feasibility study.

Authors:  Olukayode A Arowolo; Uchenna O Njiaju; Temidayo O Ogundiran; Oyewale Abidoye; Olukayode O Lawal; Millicent Obajimi; Adebayo V Adetiloye; Hae K Im; Akinbolaji A Akinkuolie; Abideen Oluwasola; Kayode Adelusola; Adesunkanmi A Kayode; Augustine E Agbakwuru; Helen Oduntan; Chinedum P Babalola; Gini Fleming; Olusola C Olopade; Adeyinka Gladys Falusi; Muheez A Durosinmi; Olufunmilayo I Olopade
Journal:  Breast J       Date:  2013-07-19       Impact factor: 2.431

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.